SUMO-modified insulin-like growth factor 1 receptor (IGF-1R) increases cell cycle progression and cell proliferation

Yingbo Lin1, Hongyu Liu1,2, Ahmed Waraky1

  • 1Department of Oncology and Pathology, CCK R8: 04, Karolinska Institutet, Stockholm, Sweden.

Insights

Nuclear localization of insulin-like growth factor 1 receptor (nIGF-1R) is linked to cancer outcomes. SUMOylation of nIGF-1R is crucial for its role in cell proliferation and gene expression, impacting cancer progression.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Signaling

Background:

  • Nuclear localization of insulin-like growth factor 1 receptor (nIGF-1R) is observed in tumor cells and associated with poor clinical outcomes.
  • The precise physiological roles of nIGF-1R within the cell nucleus remain largely undisclosed.
  • Previous research indicated that SUMOylation enables IGF-1R nuclear translocation and gene expression modulation via enhancer binding.

Purpose of the Study:

  • To investigate the role of SUMOylation in IGF-1R nuclear translocation and its impact on cell physiology.
  • To compare the effects of wild-type IGF-1R (WT) versus a SUMOylation-deficient mutant (TSM) on cell proliferation and cell cycle progression.

Main Methods:

  • Stable transfectants of wild-type IGF1R (WT) and triple-SUMO-site-mutated IGF1R (TSM) were created in igf1r knockout mouse fibroblasts.
  • Equal expression levels of IGF-1R were confirmed between R-WT and R-TSM clones.
  • Cell proliferation, nuclear translocation, and G1-S phase progression were analyzed upon IGF-1 stimulation.

Main Results:

  • Both WT and TSM IGF-1R translocated to the nucleus, with WT showing greater nuclear presence.
  • R-WT cells exhibited significantly faster proliferation and G1-S phase progression compared to R-TSM cells.
  • R-WT cells showed increased expression of cyclins D1, A, and CDK2, and decreased p27, indicating cell cycle regulation.

Conclusions:

  • SUMOylation is critical for the full proliferative and cell cycle-promoting functions of nuclear IGF-1R.
  • SUMO-IGF-1R appears to influence upstream mechanisms controlling cell cycle regulators.
  • Further research is warranted to elucidate the specific SUMO-IGF-1R-dependent pathways involved in cancer progression.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
Cells Coordinate Growth and Proliferation02:36

Cells Coordinate Growth and Proliferation

Cell size is a significant factor impacting cellular design, function, and fitness. There exists some internal coordination by which cells double their masses before division, thus, achieving homeostasis. Coordination between cell growth and proliferation depends on the checkpoints in between cell cycle phases. Loss of coordination or failure in the checkpoint mechanism can drive the cell to uncontrolled growth and loss of cellular function. Like dividing cells that coordinate cellular growth,...
5.2K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.1K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.2K
Molecular Factors Affecting Cell Division01:27

Molecular Factors Affecting Cell Division

Several external and internal factors influence the initiation and inhibition of cell division. For instance, the death of nearby cells or the release of human growth hormone (hGH) promotes cell division. In contrast, lack of hGH or crowding of cells can inhibit cell division.
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
4.0K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.7K